PDS Biotechnology
PDSB
PDSB
51 hedge funds and large institutions have $6.91M invested in PDS Biotechnology in 2024 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 17 increasing their positions, 14 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
33% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 12
58% less capital invested
Capital invested by funds: $16.5M → $6.91M (-$9.6M)
Holders
51
Holding in Top 10
–
Calls
$157K
Puts
$13K
Top Buyers
| 1 | +$184K | |
| 2 | +$172K | |
| 3 | +$125K | |
| 4 |
VF
Virtu Financial
New York
|
+$89K |
| 5 |
Two Sigma Investments
New York
|
+$78.5K |
Top Sellers
| 1 | -$455K | |
| 2 | -$287K | |
| 3 | -$176K | |
| 4 |
PAS
Point72 Asia (Singapore)
Singapore
|
-$85.7K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$69.5K |